Research from the Hamner Shows Efficacy of Alternative Method for Delivering Cancer-fighting Drugs to Lungs
The Hamner Institutes for Health Sciences has announced that Hamner scientists, with support from the National Cancer Institute, have shown that administering cancer-preventive drugs directly to target lung tissue via aspiration is an effective and inexpensive alternative to the traditional inhalation method. In the study, scientists in The Hamner’s Center for Preclinical Safety and Efficacy demonstrated that Licofelone, a novel analgesic and anti-inflammatory agent, was successful in low doses at inhibiting tumor progression in a human surrogate lung cancer model....
View full press release